Ziprasidone in the treatment of Parkinson's disease psychosis.
Shiah
I-Shin
IS
Department of Psychiatry, Tri-Service General Hospital, No. 325, Sec. 2, Cheng-Gung Road, Neihu District, Taipei 114, Taiwan, ROC. ishiah@ms45.hinet.net
Lin
Chun-Lung
CL
Mao
Wei-Chung
WC
Luu
Sy-Ueng
SU
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D010300:Parkinson Disease / Q000150:complications* / Q000523:psychology; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000150:complications* / Q000188:drug therapy* / Q000523:psychology; D013624:Taiwan; D013844:Thiazoles / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone